Crescent Biopharma (CBIO) News Today $12.92 -0.02 (-0.15%) As of 09/19/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period With 36% stake, Crescent Biopharma, Inc. (NASDAQ:CBIO) seems to have captured institutional investors' interestSeptember 17 at 10:25 PM | finance.yahoo.comCrescent Biopharma (NASDAQ:CBIO) Stock Price Crosses Above 200 Day Moving Average - Time to Sell?September 15, 2025 | marketbeat.comCrescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Rating of "Buy" from BrokeragesSeptember 7, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving Average - What's Next?September 6, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Crescent Biopharma (NASDAQ:CBIO)August 29, 2025 | marketbeat.comCrescent Biopharma to Present at September Investor ConferencesAugust 28, 2025 | globenewswire.comCrescent Biopharma (NASDAQ:CBIO) Coverage Initiated at Jefferies Financial GroupAugust 27, 2025 | marketbeat.comJefferies Initiates Coverage of Crescent Biopharma (CBIO) with Buy RecommendationAugust 25, 2025 | msn.comCrescent Biopharma initiated with a Buy at JefferiesAugust 25, 2025 | msn.comCrescent Biopharma (NASDAQ:CBIO) Shares Pass Above Two Hundred Day Moving Average - What's Next?August 22, 2025 | marketbeat.comCrescent Biopharma: Chasing The Summit HypeAugust 18, 2025 | seekingalpha.comQ3 Earnings Forecast for CBIO Issued By HC WainwrightAugust 15, 2025 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Crescent Biopharma (CBIO) with Buy RecommendationAugust 12, 2025 | msn.comCrescent Biopharma, Inc. (NASDAQ:CBIO) Given Average Rating of "Buy" by BrokeragesAugust 12, 2025 | marketbeat.comHC Wainwright Begins Coverage on Crescent Biopharma (NASDAQ:CBIO)August 12, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Releases Quarterly Earnings Results, Misses Expectations By $2.24 EPSAugust 3, 2025 | marketbeat.comWall Street Zen Downgrades Crescent Biopharma (NASDAQ:CBIO) to SellAugust 3, 2025 | marketbeat.comCrescent Biopharma: Q2 Earnings SnapshotJuly 31, 2025 | sfgate.comCrescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business HighlightsJuly 31, 2025 | finance.yahoo.comCrescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business HighlightsJuly 31, 2025 | globenewswire.comCrescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200 Day Moving Average - Here's What HappenedJuly 29, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Stock Rating Upgraded by Wall Street ZenJuly 20, 2025 | marketbeat.comWhat is Wedbush's Forecast for CBIO Q2 Earnings?July 16, 2025 | marketbeat.comWedbush Initiates Coverage of Crescent Biopharma (CBIO) with Outperform RecommendationJuly 15, 2025 | msn.comWedbush Initiates Coverage on Crescent Biopharma (NASDAQ:CBIO)July 14, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Upgraded by Wall Street Zen to Sell RatingJuly 12, 2025 | marketbeat.comCrescent Biopharma (NASDAQ:CBIO) Stock Crosses Above Two Hundred Day Moving Average - What's Next?July 11, 2025 | marketbeat.comCrescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific OfficerJuly 8, 2025 | globenewswire.comCrescent Biopharma (NASDAQ:CBIO) Shares Cross Above 200 Day Moving Average - Should You Sell?July 3, 2025 | marketbeat.comCrescent Biopharma, Inc. Common Stock (CBIO) Analyst ResearchJuly 2, 2025 | nasdaq.comCrescent Biopharma Inc. CBIO Company Vitals - U.S. NewsJune 26, 2025 | money.usnews.comStifel Initiates Coverage of Crescent Biopharma (CBIO) with Buy RecommendationJune 26, 2025 | msn.comCatalyst Biosciences, Inc. (CBIO)June 17, 2025 | finance.yahoo.comCrescent Biopharma Completes Closing of Merger with GlycoMimetics and Previously Announced Private Placement of $200 MillionJune 16, 2025 | globenewswire.comCatalyst Biosciences Inc trading halted, volatility trading pauseMarch 19, 2025 | markets.businessinsider.comBiocom California Names the Ninth Annual Life Science Catalyst Award WinnersOctober 29, 2024 | businesswire.comCatalyst Mutual FundsOctober 4, 2024 | morningstar.comMCaribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene EditingSeptember 30, 2024 | seekingalpha.comStrong Buy Recommendation for Cellectar Biosciences on Positive Phase 2b Results and Solid FinancialsAugust 17, 2024 | markets.businessinsider.comCastle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call TranscriptAugust 6, 2024 | seekingalpha.comNeurocrine Biosciences Heads Into A Catalyst-Rich 2024 With Additional UpsideFebruary 10, 2024 | seekingalpha.comBuy Rating Backed by Pivotal Trial Catalyst and Novel Drug Delivery Platform for Cellectar BiosciencesJanuary 5, 2024 | markets.businessinsider.comBiocom California Names the Eighth Annual Life Science Catalyst Award WinnersNovember 1, 2023 | businesswire.comCatalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitOctober 30, 2023 | finance.yahoo.comGeneral Catalyst in German VC tie-up as part of European tech pushOctober 23, 2023 | ft.com'Blind Side' author Michael Lewis suggests catalyst behind Michael Oher lawsuit: 'Violence and aggression'October 18, 2023 | foxnews.comIs Catalyst Biosciences (CBIO) Significantly Overvalued?August 23, 2023 | finance.yahoo.comCatalyst Biosciences (CBIO) Earnings Dates & ReportsAugust 22, 2023 | investing.comCBIO - Catalyst Biosciences, Inc.June 9, 2023 | finance.yahoo.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRTApril 28, 2023 | markets.businessinsider.com Get Crescent Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CBIO Media Mentions By Week CBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBIO News Sentiment▼0.000.79▲Average Medical News Sentiment CBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBIO Articles This Week▼20▲CBIO Articles Average Week Get the Latest News and Ratings for CBIO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Crescent Biopharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Geron News Today Zenas BioPharma News Today Myriad Genetics News Today Rigel Pharmaceuticals News Today Verastem News Today XOMA Royalty News Today Emergent Biosolutions News Today Lexicon Pharmaceuticals News Today Vanda Pharmaceuticals News Today Codexis News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBIO) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crescent Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Crescent Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
